129 related articles for article (PubMed ID: 23464407)
21. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
22. Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer.
Hwang SG; Kim KM; Cheong JH; Kim HI; An JY; Hyung WJ; Noh SH
Eur J Surg Oncol; 2012 Jul; 38(7):562-7. PubMed ID: 22592098
[TBL] [Abstract][Full Text] [Related]
23. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
24. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.
Zhuo Y; Lin L; Zhang M
Platelets; 2017 Sep; 28(6):560-566. PubMed ID: 27848258
[TBL] [Abstract][Full Text] [Related]
26. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients.
Chen YP; Zhao BC; Chen C; Shen LJ; Gao J; Mai ZY; Chen MK; Chen G; Yan F; Liu S; Xia YF
Chin J Cancer; 2015 Mar; 34(3):137-46. PubMed ID: 25962816
[TBL] [Abstract][Full Text] [Related]
28. Thrombocytosis in gynecological cancers.
Sharma D; Singh G
J Cancer Res Ther; 2017; 13(2):193-197. PubMed ID: 28643732
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Overexpressed p16INK4a in Vulvar Cancer: A Meta-Analysis.
Cao H; Wang S; Zhang Z; Lou J
PLoS One; 2016; 11(3):e0152459. PubMed ID: 27031618
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Elevated Platelet Count as a Prognostic Factor in Vulvar Squamous Cell Cancer: A Mini-review.
Abu-Zaid A; Alomar O; Salem H
Cureus; 2018 Mar; 10(3):e2279. PubMed ID: 29736362
[TBL] [Abstract][Full Text] [Related]
31. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytosis in advanced epithelial ovarian cancer.
Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
[TBL] [Abstract][Full Text] [Related]
33. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis.
Bai YY; Du L; Jing L; Tian T; Liang X; Jiao M; Nan KJ; Guo H; Ruan ZP
Cancer Manag Res; 2019; 11():4283-4295. PubMed ID: 31190994
[No Abstract] [Full Text] [Related]
35. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
Lee M; Kim SW; Nam EJ; Yim GW; Kim S; Kim YT
Gynecol Oncol; 2011 Aug; 122(2):238-41. PubMed ID: 21531448
[TBL] [Abstract][Full Text] [Related]
36. Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies.
Abu-Zaid A; Alomar O; Al-Badawi IA; Salem H
Arch Gynecol Obstet; 2018 Apr; 297(4):1071-1072. PubMed ID: 29404744
[No Abstract] [Full Text] [Related]
37. Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study).
Hernandez E; Heller PB; Whitney C; Diana K; Delgado G
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):328-32. PubMed ID: 7835768
[TBL] [Abstract][Full Text] [Related]
38. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
[TBL] [Abstract][Full Text] [Related]
39. Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Taucher S; Salat A; Gnant M; Kwasny W; Mlineritsch B; Menzel RC; Schmid M; Smola MG; Stierer M; Tausch C; Galid A; Steger G; Jakesz R;
Thromb Haemost; 2003 Jun; 89(6):1098-106. PubMed ID: 12783124
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
